ArticleFrontiers in pharmacology2022

The influence of pharmaceutical care in patients with advanced non-small-cell lung cancer receiving combination cytotoxic chemotherapy and PD-1/PD-L1 inhibitors.

Wen Kou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.